These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 30872410)
21. Microarray technology to investigate genes associated with papillary thyroid carcinoma. Zhu X; Yao J; Tian W Mol Med Rep; 2015 May; 11(5):3729-33. PubMed ID: 25586635 [TBL] [Abstract][Full Text] [Related]
22. Special role of JUN in papillary thyroid carcinoma based on bioinformatics analysis. Chen W; Liu Q; Lv Y; Xu D; Chen W; Yu J World J Surg Oncol; 2017 Jul; 15(1):119. PubMed ID: 28673327 [TBL] [Abstract][Full Text] [Related]
23. Identification of potential targetable genes in papillary, follicular, and anaplastic thyroid carcinoma using bioinformatics analysis. Agarwal S; Gupta S; Raj R Endocrine; 2024 Oct; 86(1):255-267. PubMed ID: 38676768 [TBL] [Abstract][Full Text] [Related]
25. Competing endogenous RNA regulatory network in papillary thyroid carcinoma. Chen S; Fan X; Gu H; Zhang L; Zhao W Mol Med Rep; 2018 Jul; 18(1):695-704. PubMed ID: 29767230 [TBL] [Abstract][Full Text] [Related]
26. Identification of Genes Associated with Papillary Thyroid Carcinoma (PTC) for Diagnosis by Integrated Analysis. Li WB; Zhou J; Xu L; Su XL; Liu Q; Pang H Horm Metab Res; 2016 Apr; 48(4):226-31. PubMed ID: 26756467 [TBL] [Abstract][Full Text] [Related]
27. Naive and regulatory B-cell transcription patterns guide the increased risk of papillary thyroid carcinoma in obesity. Yu Z; Xu Z; Li S; Tian Z; Yuan J Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):118-126. PubMed ID: 38678617 [TBL] [Abstract][Full Text] [Related]
28. Identifying gene modules of thyroid cancer associated with pathological stage by weighted gene co-expression network analysis. Tang X; Huang X; Wang D; Yan R; Lu F; Cheng C; Li Y; Xu J Gene; 2019 Jul; 704():142-148. PubMed ID: 30965127 [TBL] [Abstract][Full Text] [Related]
29. Transcriptome Analyses Identify a Metabolic Gene Signature Indicative of Dedifferentiation of Papillary Thyroid Cancer. Ma B; Jiang H; Wen D; Hu J; Han L; Liu W; Xu W; Shi X; Wei W; Liao T; Wang Y; Lu Z; Wang Y; Ji Q J Clin Endocrinol Metab; 2019 Sep; 104(9):3713-3725. PubMed ID: 30942873 [TBL] [Abstract][Full Text] [Related]
30. Investigating the mechanisms of papillary thyroid carcinoma using transcriptome analysis. Qiu J; Zhang W; Xia Q; Liu F; Zhao S; Zhang K; Chen M; Zang C; Ge R; Liang D; Sun Y Mol Med Rep; 2017 Nov; 16(5):5954-5964. PubMed ID: 28849102 [TBL] [Abstract][Full Text] [Related]
31. Identification of differentially expressed genes and signaling pathways in papillary thyroid cancer: a study based on integrated microarray and bioinformatics analysis. Sun T; Guan Q; Wang Y; Qian K; Sun W; Ji Q; Wu Y; Guo K; Xiang J Gland Surg; 2021 Feb; 10(2):629-644. PubMed ID: 33708546 [TBL] [Abstract][Full Text] [Related]
32. Biomarkers related to m6A and succinic acid metabolism in papillary thyroid carcinoma. Li M; Fu X; Zhou T; Han H BMC Med Genomics; 2024 Aug; 17(1):199. PubMed ID: 39113023 [TBL] [Abstract][Full Text] [Related]
33. Identification of Biomarkers Based on Differentially Expressed Genes in Papillary Thyroid Carcinoma. Han J; Chen M; Wang Y; Gong B; Zhuang T; Liang L; Qiao H Sci Rep; 2018 Jul; 8(1):9912. PubMed ID: 29967488 [TBL] [Abstract][Full Text] [Related]
34. Genome-wide scanning for CHD1L gene in papillary thyroid carcinoma complicated with type 2 diabetes mellitus. Kang YY; Li JJ; Sun JX; Wei JX; Ding C; Shi CL; Wu G; Li K; Ma YF; Sun Y; Qiao H Clin Transl Oncol; 2021 Dec; 23(12):2536-2547. PubMed ID: 34245428 [TBL] [Abstract][Full Text] [Related]
35. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer. Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489 [TBL] [Abstract][Full Text] [Related]
36. Identification of potential pathogenic candidates or diagnostic biomarkers in papillary thyroid carcinoma using expression and methylation profiles. Wei S; Yun X; Ruan X; Wei X; Zheng X; Gao M Oncol Lett; 2019 Dec; 18(6):6670-6678. PubMed ID: 31814850 [TBL] [Abstract][Full Text] [Related]
37. GADD45B Transcript Is a Prognostic Marker in Papillary Thyroid Carcinoma Patients Treated With Total Thyroidectomy and Radioiodine Therapy. Barros-Filho MC; de Mello JBH; Marchi FA; Pinto CAL; da Silva IC; Damasceno PKF; Soares MBP; Kowalski LP; Rogatto SR Front Endocrinol (Lausanne); 2020; 11():269. PubMed ID: 32425887 [TBL] [Abstract][Full Text] [Related]
38. Identification of hub genes in papillary thyroid carcinoma: robust rank aggregation and weighted gene co-expression network analysis. Liu Y; Chen TY; Yang ZY; Fang W; Wu Q; Zhang C J Transl Med; 2020 Apr; 18(1):170. PubMed ID: 32299435 [TBL] [Abstract][Full Text] [Related]
39. Comprehensive analysis of lncRNA-mediated ceRNA network in papillary thyroid cancer. Sun Y; Dai WR; Xia N Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10003-10014. PubMed ID: 33090405 [TBL] [Abstract][Full Text] [Related]
40. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis. Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]